Improved Glycemic Outcomes With Diabetes Technology Use Independent of Socioeconomic Status in Youth With Type 1 Diabetes.

Autor:	Lomax KE; Department of Endocrinology and Diabetes, Perth Children's Hospital, Nedlands, Western Australia, Australia.; Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia., Taplin CE; Department of Endocrinology and Diabetes, Perth Children's Hospital, Nedlands, Western Australia, Australia.; Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia.; Centre for Child Health Research, The University of Western Australia, Perth, Western Australia, Australia., Abraham MB; Department of Endocrinology and Diabetes, Perth Children's Hospital, Nedlands, Western Australia, Australia.; Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia.; Division of Paediatrics Within the Medical School, The University of Western Australia, Perth, Western Australia, Australia., Smith GJ; Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia., Haynes A; Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia., Zomer E; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia., Ellis KL; Department of Endocrinology and Diabetes, Perth Children's Hospital, Nedlands, Western Australia, Australia., Clapin H; Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia., Zoungas S; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia., Jenkins AJ; Diabetes and Vascular Medicine, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.; NHMRC Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia., Harrington J; Division of Endocrinology, Women's and Children's Health Network, North Adelaide, South Australia, Australia.; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia., de Bock MI; Department of Paediatrics, University of Otago, Christchurch, New Zealand., Jones TW; Department of Endocrinology and Diabetes, Perth Children's Hospital, Nedlands, Western Australia, Australia.; Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia.; Division of Paediatrics Within the Medical School, The University of Western Australia, Perth, Western Australia, Australia., Davis EA; Department of Endocrinology and Diabetes, Perth Children's Hospital, Nedlands, Western Australia, Australia.; Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia.; Division of Paediatrics Within the Medical School, The University of Western Australia, Perth, Western Australia, Australia.
Jazyk:	angličtina
Zdroj:	Diabetes care [Diabetes Care] 2024 Apr 01; Vol. 47 (4), pp. 707-711.
DOI:	10.2337/dc23-2033
Abstrakt:	Objective: Technology use in type 1 diabetes (T1D) is impacted by socioeconomic status (SES). This analysis explored relationships between SES, glycemic outcomes, and technology use. Research Design and Methods: A cross-sectional analysis of HbA1c data from 2,822 Australian youth with T1D was undertaken. Residential postcodes were used to assign SES based on the Index of Relative Socio-Economic Disadvantage (IRSD). Linear regression models were used to evaluate associations among IRSD quintile, HbA1c, and management regimen. Results: Insulin pump therapy, continuous glucose monitoring, and their concurrent use were associated with lower mean HbA1c across all IRSD quintiles (P < 0.001). There was no interaction between technology use and IRSD quintile on HbA1c (P = 0.624), reflecting a similar association of lower HbA1c with technology use across all IRSD quintiles. Conclusions: Technology use was associated with lower HbA1c across all socioeconomic backgrounds. Socioeconomic disadvantage does not preclude glycemic benefits of diabetes technologies, highlighting the need to remove barriers to technology access. (© 2024 by the American Diabetes Association.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu